1-6 of 6
Shau-Hsuan Li
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase II, Randomized Study of Spartalizumab (PDR001), an Anti–PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer

Available to Purchase
Caroline Even, Hung-Ming Wang, Shau-Hsuan Li, Roger K-C Ngan, Arunee Dechaphunkul, Li Zhang, Chia-Jui Yen, Po Chung Chan, Somvilai Chakrabandhu, Brigette B.Y. Ma, Suebpong Tanasanvimon, Victor H.F. Lee, Pei-Jen Lou, Zujun Li, Alexander I. Spira, Ammar Sukari, Joël Guigay, Steven McCune, Juan Gonzalez-Maffe, Sebastian Szpakowski, Yao Yao, Hongzi Liang, Jennifer Mataraza, Romain Séchaud, Luigi Manenti, Darren W-T. Lim
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (23): 6413–6423.
https://doi.org/10.1158/1078-0432.CCR-21-0822
Published: 01 December 2021
View articletitled, Phase II, Randomized Study of Spartalizumab (PDR001), an Anti–PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer
Open the PDF for Phase II, Randomized Study of Spartalizumab (PDR001), an Anti–PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer in another window
Includes: Supplementary data
Journal Articles

Molecular Alterations and Buparlisib Efficacy in Patients with Squamous Cell Carcinoma of the Head and Neck: Biomarker Analysis from BERIL-1

Free
Denis Soulières, Lisa Licitra, Ricard Mesía, Éva Remenár, Shau-Hsuan Li, Andrey Karpenko, Marie Chol, Ying A. Wang, Nadia Solovieff, Laurence Bourdeau, Dalila Sellami, Sandrine Faivre
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (11): 2505–2516.
https://doi.org/10.1158/1078-0432.CCR-17-2644
Published: 31 May 2018
View articletitled, Molecular Alterations and Buparlisib Efficacy in Patients with Squamous Cell Carcinoma of the Head and Neck: Biomarker Analysis from BERIL-1
Open the PDF for Molecular Alterations and Buparlisib Efficacy in Patients with Squamous Cell Carcinoma of the Head and Neck: Biomarker Analysis from BERIL-1 in another window
Includes: Supplementary data
Journal Articles

AMACR Amplification in Myxofibrosarcomas: A Mechanism of Overexpression That Promotes Cell Proliferation with Therapeutic Relevance

Free
Chien-Feng Li, Fu-Min Fang, Jui Lan, Jun-Wen Wang, Hsing-Jien Kung, Li-Tzong Chen, Tzu-Ju Chen, Shau-Hsuan Li, Yu-Hui Wang, Hui-Chun Tai, Shih-Chen Yu, Hsuan-Ying Huang
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (23): 6141–6152.
https://doi.org/10.1158/1078-0432.CCR-14-1182
Published: 30 November 2014
View articletitled, AMACR Amplification in Myxofibrosarcomas: A Mechanism of Overexpression That Promotes Cell Proliferation with Therapeutic Relevance
Open the PDF for AMACR Amplification in Myxofibrosarcomas: A Mechanism of Overexpression That Promotes Cell Proliferation with Therapeutic Relevance in another window
Includes: Supplementary data
Journal Articles

ASS1 as a Novel Tumor Suppressor Gene in Myxofibrosarcomas: Aberrant Loss via Epigenetic DNA Methylation Confers Aggressive Phenotypes, Negative Prognostic Impact, and Therapeutic Relevance

Free
Hsuan-Ying Huang, Wen-Ren Wu, Yu-Hui Wang, Jun-Wen Wang, Fu-Min Fang, Jen-Wei Tsai, Shau-Hsuan Li, Hsiao-Chin Hung, Shih-Chen Yu, Jui Lan, Yow-Ling Shiue, Chung-His Hsing, Li-Tzong Chen, Chien-Feng Li
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (11): 2861–2872.
https://doi.org/10.1158/1078-0432.CCR-12-2641
Published: 30 May 2013
View articletitled, ASS1 as a Novel Tumor Suppressor Gene in Myxofibrosarcomas: Aberrant Loss via Epigenetic DNA Methylation Confers Aggressive Phenotypes, Negative Prognostic Impact, and Therapeutic Relevance
Open the PDF for ASS1 as a Novel Tumor Suppressor Gene in Myxofibrosarcomas: Aberrant Loss via Epigenetic DNA Methylation Confers Aggressive Phenotypes, Negative Prognostic Impact, and Therapeutic Relevance in another window
Includes: Supplementary data
Journal Articles

Characterization of Gene Amplification–Driven SKP2 Overexpression in Myxofibrosarcoma: Potential Implications in Tumor Progression and Therapeutics

Free
Chien-Feng Li, Ju-Ming Wang, Hong-Yo Kang, Chiung-Kuei Huang, Jun-Wen Wang, Fu-Min Fang, Yu-Hui Wang, Wen-Ren Wu, Shau-Hsuan Li, Shih-Chen Yu, Jen-Chieh Lee, Jui Lan, Yow-Ling Shiue, Li-Ching Wu, Hsuan-Ying Huang
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (6): 1598–1610.
https://doi.org/10.1158/1078-0432.CCR-11-3077
Published: 14 March 2012
View articletitled, Characterization of Gene Amplification–Driven SKP2 Overexpression in Myxofibrosarcoma: Potential Implications in Tumor Progression and Therapeutics
Open the PDF for Characterization of Gene Amplification–Driven SKP2 Overexpression in Myxofibrosarcoma: Potential Implications in Tumor Progression and Therapeutics in another window
Includes: Supplementary data
Journal Articles

Homozygous Deletion of MTAP Gene as a Poor Prognosticator in Gastrointestinal Stromal Tumors

Free
Hsuan-Ying Huang, Shau-Hsuan Li, Shih-Chen Yu, Fong-Fu Chou, Ching-Cherng Tzeng, Tsung-Hui Hu, Yih-Huei Uen, Yu-Fang Tian, Yu-Hui Wang, Fu-Min Fang, Wen-Wei Huang, Yu-Ching Wei, Jing-Mei Wu, Chien-Feng Li
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (22): 6963–6972.
https://doi.org/10.1158/1078-0432.CCR-09-1511
Published: 11 November 2009
View articletitled, Homozygous Deletion of MTAP Gene as a Poor Prognosticator in Gastrointestinal Stromal Tumors
Open the PDF for Homozygous Deletion of MTAP Gene as a Poor Prognosticator in Gastrointestinal Stromal Tumors in another window
Includes: Supplementary data